Cormorant Private Healthcare Fund Ii, Lp - Net Worth and Insider Trading

In summary, during the past 3 months, insiders sold 0 shares of Akouos Inc (AKUS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Akouos Inc (AKUS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Akouos Inc (AKUS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Cormorant Private Healthcare Fund Ii, Lp made no insider transaction in Avidity Biosciences Inc (RNA). Other recent insider transactions involving Avidity Biosciences Inc (RNA) include a net sale of 224,600 shares made by Arthur A Levin , a net sale of 551,092 shares made by Sarah Boyce , and a net sale of 220,861 shares made by Michael F Maclean .

In summary, during the past 3 months, insiders sold 693,245 shares of Avidity Biosciences Inc (RNA) in total and bought 0 shares, with a net sale of 693,245 shares. During the past 18 months, 1,002,747 shares of Avidity Biosciences Inc (RNA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,002,747 shares.

Avidity Biosciences Inc (RNA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Cormorant Private Healthcare Fund Ii, Lp made no insider transaction in Atea Pharmaceuticals Inc (AVIR). Other recent insider transactions involving Atea Pharmaceuticals Inc (AVIR) include a net sale of 57,916 shares made by Jean-pierre Sommadossi , a net sale of 15,870 shares made by Maria Arantxa Horga , and a net sale of 15,843 shares made by Andrea Corcoran .

In summary, during the past 3 months, insiders sold 1,006 shares of Atea Pharmaceuticals Inc (AVIR) in total and bought 0 shares, with a net sale of 1,006 shares. During the past 18 months, 127,954 shares of Atea Pharmaceuticals Inc (AVIR) were sold and 0 shares were bought by its insiders, resulting in a net sale of 127,954 shares.

Atea Pharmaceuticals Inc (AVIR)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Cormorant Private Healthcare Fund Ii, Lp made no insider transaction in Rain Oncology Inc (RAIN). Other recent insider transactions involving Rain Oncology Inc (RAIN) include a net purchase of 1,198,445 shares made by Kevin C Tang , and a net sale of 995,000 shares made by Boxer Capital, Llc .

In summary, during the past 3 months, insiders sold 0 shares of Rain Oncology Inc (RAIN) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 1,168,973 shares of Rain Oncology Inc (RAIN) were sold and 1,372,418 shares were bought by its insiders, resulting in a net purchase of 203,445 shares.

Rain Oncology Inc (RAIN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Cormorant Private Healthcare Fund Ii, Lp made no insider transaction in Olema Pharmaceuticals inc (OLMA). Other recent insider transactions involving Olema Pharmaceuticals inc (OLMA) include a net sale of 308,181 shares made by Cyrus Harmon , a net sale of 44,370 shares made by David C. Myles , and a net sale of 535,000 shares made by G. Walmsley Graham .

In summary, during the past 3 months, insiders sold 1,240,000 shares of Olema Pharmaceuticals inc (OLMA) in total and bought 0 shares, with a net sale of 1,240,000 shares. During the past 18 months, 1,618,074 shares of Olema Pharmaceuticals inc (OLMA) were sold and 2,255,932 shares were bought by its insiders, resulting in a net purchase of 637,858 shares.

Olema Pharmaceuticals inc (OLMA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Cormorant Private Healthcare Fund Ii, Lp made no insider transaction in Erasca Inc (ERAS). Other recent insider transactions involving Erasca Inc (ERAS) include a net purchase of 2,260,000 shares made by Jonathan E Lim , a net purchase of 130,000 shares made by Alexander W. Casdin , and a net purchase of 20,000 shares made by Start Valerie Denise Harding .

In summary, during the past 3 months, insiders sold 0 shares of Erasca Inc (ERAS) in total and bought 80,000 shares, with a net purchase of 80,000 shares. During the past 18 months, 0 shares of Erasca Inc (ERAS) were sold and 2,430,000 shares were bought by its insiders, resulting in a net purchase of 2,430,000 shares.

Erasca Inc (ERAS)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Cormorant Private Healthcare Fund Ii, Lp made no insider transaction in Aerovate Therapeutics Inc (AVTE). Other recent insider transactions involving Aerovate Therapeutics Inc (AVTE) include a net sale of 183,134 shares made by Benjamin T Dake , a net sale of 68,255 shares made by Hunter Gillies , and a net sale of 138,142 shares made by Timothy P Noyes .

In summary, during the past 3 months, insiders sold 153,793 shares of Aerovate Therapeutics Inc (AVTE) in total and bought 0 shares, with a net sale of 153,793 shares. During the past 18 months, 534,668 shares of Aerovate Therapeutics Inc (AVTE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 534,668 shares.

Aerovate Therapeutics Inc (AVTE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Cormorant Private Healthcare Fund Ii, Lp made no insider transaction in Design Therapeutics Inc (DSGN). Other recent insider transactions involving Design Therapeutics Inc (DSGN) include a net purchase of 2,235,000 shares made by Arsani William , a net purchase of 900,000 shares made by Sr One Capital Fund I Aggregator Lp , and a net purchase of 900,000 shares made by Simeon George .

In summary, during the past 3 months, insiders sold 0 shares of Design Therapeutics Inc (DSGN) in total and bought 28,265 shares, with a net purchase of 28,265 shares. During the past 18 months, 0 shares of Design Therapeutics Inc (DSGN) were sold and 4,103,715 shares were bought by its insiders, resulting in a net purchase of 4,103,715 shares.

Design Therapeutics Inc (DSGN)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Cormorant Private Healthcare Fund Ii, Lp made no insider transaction in Monte Rosa Therapeutics Inc (GLUE). Other recent insider transactions involving Monte Rosa Therapeutics Inc (GLUE) include a net sale of 1,207 shares made by Edmund Dunn ,

In summary, during the past 3 months, insiders sold 1,207 shares of Monte Rosa Therapeutics Inc (GLUE) in total and bought 0 shares, with a net sale of 1,207 shares. During the past 18 months, 1,207 shares of Monte Rosa Therapeutics Inc (GLUE) were sold and 0 shares were bought by its insiders, resulting in a net sale of 1,207 shares.

Monte Rosa Therapeutics Inc (GLUE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Cormorant Private Healthcare Fund Ii, Lp made no insider transaction in BioAtla Inc (BCAB). Other recent insider transactions involving BioAtla Inc (BCAB) include a net purchase of 10,000 shares made by Sylvia Mcbrinn , a net purchase of 90,800 shares made by Short Jay M Phd , and a net purchase of 27,495 shares made by Christian Vasquez .

In summary, during the past 3 months, insiders sold 0 shares of BioAtla Inc (BCAB) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of BioAtla Inc (BCAB) were sold and 148,295 shares were bought by its insiders, resulting in a net purchase of 148,295 shares.

BioAtla Inc (BCAB)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Cormorant Private Healthcare Fund Ii, Lp made no insider transaction in GreenLight Biosciences Holdings PBC (GRNA). Other recent insider transactions involving GreenLight Biosciences Holdings PBC (GRNA) include a net sale of 9,188,659 shares made by Cormorant Global Healthcare Master Fund, Lp ,

In summary, during the past 3 months, insiders sold 0 shares of GreenLight Biosciences Holdings PBC (GRNA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 9,188,659 shares of GreenLight Biosciences Holdings PBC (GRNA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 9,188,659 shares.

GreenLight Biosciences Holdings PBC (GRNA)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Environmental Impact Acquisition Corp (ENVIU) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Environmental Impact Acquisition Corp (ENVIU) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Environmental Impact Acquisition Corp (ENVIU)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Cormorant Private Healthcare Fund Ii, Lp made no insider transaction in MoonLake Immunotherapeutics (MLTX). Other recent insider transactions involving MoonLake Immunotherapeutics (MLTX) include a net purchase of 1,629,151 shares made by Bihua Chen , a net sale of 200,000 shares made by Kristian Reich , and a net sale of 184,740 shares made by Santos Da Silva Jorge .

In summary, during the past 3 months, insiders sold 0 shares of MoonLake Immunotherapeutics (MLTX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 484,740 shares of MoonLake Immunotherapeutics (MLTX) were sold and 1,629,151 shares were bought by its insiders, resulting in a net purchase of 1,144,411 shares.

MoonLake Immunotherapeutics (MLTX)'s detailed insider trading history can be found in Insider Trading Tracker table.